Alec Cutler
Alec Cutler joined Orbis Investment in 2004. Based in Bermuda, he leads the multi-asset team, is one of the portfolio managers for the Orbis Global Balanced Strategy, and has overall responsibility for the strategy. He previously worked for ten years at Brandywine Asset Management LLC managing the Relative Value strategy, co-managing the Large Cap Value area and co-managing the firm as a member of the executive committee.
Alec holds a Bachelor of Science degree in naval architecture from the United States Naval Academy, a Master of Business Administration from the Wharton School of the University of Pennsylvania, and is a Chartered Financial Analyst.
Latest articles by Alec Cutler
-
A selection of attractive stocks for troubled times
Tips Professional investor Alec Cutler of the Orbis Global Balanced Fund picks two well-placed stocks and a key investment theme to buy now.
By Alec Cutler Published
Tips -
Beyond US tech stocks: three global stars to buy now
Tips There is much to like about the US tech giants, says professional investor Alec Cutler of Orbis Investments highlights. But there are many other excellent businesses out there trading at much more attractive valuations. Here are three of his favourites.
By Alec Cutler Last updated
Tips -
Market panic creates bargains for the brave
Tips There are plenty of opportunities still available for long-term investors, says Alec Cutler of Orbis Investments. Here, he picks three undervalued long-term winners.
By Alec Cutler Published
Tips -
Contrarian picks that promise big profits
Opinion Alec Cutler of Orbis Global Balanced Fund finds three stocks ripe with opportunity.
By Alec Cutler Published
Opinion -
Three stocks that are ripe with opportunity
Opinion Professional investor Alec Cutler picks three stocks that have been victims of excessive pessimism that has obscured their promising long-term prospects.
By Alec Cutler Published
Opinion -
Four unwanted defensive stocks going cheap
Opinion Professional investor Alec Cutler tips four unwanted defensives, including oil majors and drug companies, to buy now.
By Alec Cutler Published
Opinion